TQQQ:NSD-ProShares UltraPro QQQ (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 72.49

Change

+0.56 (+0.78)%

Market Cap

USD 24.55B

Volume

0.04B

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes 100 of the largest domestic and international non-financial companies listed on The Nasdaq Stock Market based on market capitalization. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
BIB ProShares Ultra Nasdaq Biotech..

+0.57 (+0.89%)

USD 0.09B

ETFs Containing TQQQ

QQH HCM Defender 100 Index ET.. 18.82 % 0.00 %

+0.19 (+0.30%)

USD 0.50B
GTAA 0.00 % 1.25 %

N/A

N/A
HUSE 0.00 % 0.91 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 42.98% 75% C 88% B+
Dividend Return 1.44% 75% C 33% F
Total Return 44.41% 75% C 89% A-
Trailing 12 Months  
Capital Gain 98.77% 75% C 93% A
Dividend Return 2.61% 75% C 39% F
Total Return 101.38% 75% C 93% A
Trailing 5 Years  
Capital Gain 408.17% 75% C 96% N/A
Dividend Return 10.33% 75% C 39% F
Total Return 418.50% 75% C 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 57.02% N/A N/A 91% A-
Dividend Return 57.77% N/A N/A 91% A-
Total Return 0.74% N/A N/A 19% F
Risk Return Profile  
Volatility (Standard Deviation) 89.25% N/A N/A 20% F
Risk Adjusted Return 64.73% N/A N/A 86% B+
Market Capitalization 24.55B 75% C 97% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike